GPIHBP1 and Plasma Triglyceride Metabolism

Trends Endocrinol Metab. 2016 Jul;27(7):455-469. doi: 10.1016/j.tem.2016.04.013. Epub 2016 May 14.

Abstract

GPIHBP1, a GPI-anchored protein in capillary endothelial cells, is crucial for the lipolytic processing of triglyceride-rich lipoproteins (TRLs). GPIHBP1 shuttles lipoprotein lipase (LPL) to its site of action in the capillary lumen and is essential for the margination of TRLs along capillaries - such that lipolytic processing can proceed. GPIHBP1 also reduces the unfolding of the LPL catalytic domain, thereby stabilizing LPL catalytic activity. Many different GPIHBP1 mutations have been identified in patients with severe hypertriglyceridemia (chylomicronemia), the majority of which interfere with folding of the protein and abolish its capacity to bind and transport LPL. The discovery of GPIHBP1 has substantially revised our understanding of intravascular triglyceride metabolism but has also raised many new questions for future research.

Keywords: LU (Ly6/uPAR) protein family; chylomicronemia; endothelial cells; hypertriglyceridemia; lipid transport; lipoprotein lipase.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Humans
  • Hypertriglyceridemia / blood
  • Hypertriglyceridemia / metabolism
  • Lipoprotein Lipase / genetics
  • Lipoprotein Lipase / metabolism
  • Receptors, Lipoprotein / genetics
  • Receptors, Lipoprotein / metabolism*
  • Triglycerides / blood*
  • Triglycerides / metabolism

Substances

  • GPIHBP1 protein, human
  • Receptors, Lipoprotein
  • Triglycerides
  • Lipoprotein Lipase